8 completed. 4 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
Follow emixustat: new trials by email Literature Review of emixustat trials Research Report on emixustat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Emixustat in Stargardt Disease Emixustat, Placebo - Stargardt Disease | Phase 3 | Completed | Kubota Vision Inc. | 194 | 2019-01-07 | 2024-05-30 |
| Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease Emixustat - Stargardt Disease, Macular Atrophy | Phase 2 | Completed | Kubota Vision Inc. | 23 | 2017-01-01 | 2021-05-19 |
| Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy emixustat hydrochloride, Placebo - Proliferative Diabetic Retinopathy | Phase 2 | Completed | Kubota Vision Inc. | 24 | 2016-05-01 | 2021-05-19 |
| Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Emixustat HCl Tablet, Placebo Tablet - Geographic Atrophy, Age-Related Macular Degeneration | Phase 1 | Completed | Kubota Vision Inc. | 26 | 2014-04-01 | 2016-01-18 |
| Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride ACU-4429, Placebo - Geographic Atrophy | Phase 2 / Phase 3 | Completed | Kubota Vision Inc. | 508 | 2013-02-01 | 2017-07-02 |
| Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy ACU-4429, Matching placebo - Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | Completed | Kubota Vision Inc. | 72 | 2009-10-01 | 2014-03-11 |
| Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects ACU-4429, matching placebo tablet - Healthy | Phase 1 | Completed | Kubota Vision Inc. | 40 | 2009-07-01 | 2012-01-10 |
| Safety and Tolerability of ACU-4429 ACU-4429, matching placebo - Healthy | Phase 1 | Completed | Kubota Vision Inc. | 46 | 2008-05-01 | 2012-06-27 |
Geographic Atrophy (3) · Stargardt Disease (2) · Anetoderma (1) · Macular Degeneration (1)
United States (8) · Brazil (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · South Africa (1) · Spain (1) · United Kingdom (1)
Jeff Gregory, MD (1) · John W Chandler, MD (1) · William Lewis, MD (1) · William W Lewis, M.D. (1)